These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical inquiries. What is the most effective treatment for ADHD in children? Johnson LA; Safranek S; Friemoth J J Fam Pract; 2005 Feb; 54(2):166-8. PubMed ID: 15689294 [No Abstract] [Full Text] [Related]
11. Benefit of long-term stimulants on driving in adults with ADHD. Jerome L; Segal A J Nerv Ment Dis; 2001 Jan; 189(1):63-4. PubMed ID: 11206669 [No Abstract] [Full Text] [Related]
12. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults. Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu E; Erder MH J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Hodgkins P; Sasané R; Meijer WM Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704 [TBL] [Abstract][Full Text] [Related]
14. Symposium on attention deficit hyperactivity disorder (ADHD). Paterson R Aust N Z J Psychiatry; 2003 Apr; 37(2):242-3; author reply 243. PubMed ID: 12656970 [No Abstract] [Full Text] [Related]
15. Fragile X: treatment of hyperactivity. Hagerman R Pediatrics; 1997 May; 99(5):753. PubMed ID: 9157389 [No Abstract] [Full Text] [Related]
16. Combining methylphenidate and clonidine: a clinically sound medication option. Wilens TE; Spencer TJ; Swanson JM; Connor DF; Cantwell D J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):614-9; discussion 619-22. PubMed ID: 10230195 [No Abstract] [Full Text] [Related]
17. Methylphenidate versus dextroamphetamine in ADHD. Efron D J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):500. PubMed ID: 10230180 [No Abstract] [Full Text] [Related]
18. Single-dose effects on the P3no-go ERP component predict clinical response to stimulants in pediatric ADHD. Ogrim G; Aasen IE; Brunner JF Clin Neurophysiol; 2016 Oct; 127(10):3277-87. PubMed ID: 27567447 [TBL] [Abstract][Full Text] [Related]
19. Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder. McGough JJ; Greenbaum M; Adeyi B; Babcock T; Scheckner B; Dirks B; Findling RL J Clin Psychopharmacol; 2012 Feb; 32(1):138-40. PubMed ID: 22217951 [No Abstract] [Full Text] [Related]
20. Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial. Ramtvedt BE; Sundet K Clin Neuropsychol; 2014; 28(7):1146-61. PubMed ID: 25249305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]